share_log

HC Wainwright & Co. Reiterates Buy on Olema Pharmaceuticals, Maintains $30 Price Target

Benzinga ·  Mar 19 10:17

HC Wainwright & Co. analyst Emily Bodnar reiterates Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and maintains $30 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 232

Recommended

Write a comment